DJ-1 can be secreted into the blood by cancer cells and serum DJ-1 is reported to be elevated in pancreatic cancer (He et al., 2011), which suggest that serum DJ-1 might be used as a potential biomarker reflecting tumor occurrence and development. The gene discussed is PARK7; the disease is cancer.